Safety and efficacy of remimazolam compared with midazolam during bronchoscopy: a single-center, randomized controlled study

Although remimazolam is an ultra-short-acting benzodiazepine with a shorter elimination half-life and faster recovery time than midazolam, studies evaluating its safety and efficacy during bronchoscopy are limited. This study aimed to compare the safety and efficacy of remimazolam with those of mida...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sun-Hyung, Cho, Jun Yeun, Kim, Miyeon, Chung, Ji Min, Yang, Jiyoul, Seong, Changhwan, Kim, Eung-Gook, Seok, Jeong Won, Shin, Yoon Mi, Lee, Ki Man, Choe, Kang Hyeon, Han, Joung-Ho, Yang, Bumhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665376/
https://www.ncbi.nlm.nih.gov/pubmed/37993525
http://dx.doi.org/10.1038/s41598-023-47271-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665376/
https://www.ncbi.nlm.nih.gov/pubmed/37993525
http://dx.doi.org/10.1038/s41598-023-47271-w

Ejemplares similares